Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2015 Update
Genomic Health, Inc. (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The companys commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It conducts extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco...
View full press release